肝细胞增殖与肝细胞癌中的脂质重塑
该研究整合代谢组学、脂质组学和转录组学,分析肝再生、药物及遗传激活的细胞增殖和肝细胞癌模型,发现增殖肝细胞脂质组改变与脂肪生成、脂肪酸去饱和及磷脂酰胆碱生成相关,并在人肝细胞癌中验证,单不饱和磷脂酰胆碱与细胞增殖和肝癌发生标志正相关。
要点
- 增殖肝细胞中脂质代谢通路(脂肪生成、去饱和、PC生成)一致性改变。
- 人肝细胞癌中验证了该脂质特征,单不饱和PC与增殖和致癌标志正相关。
- 特定脂质代谢通路可为肝癌治疗策略和预后生物标志物开发提供靶点。
核心结论
- 肝细胞转向增殖时特定脂质代谢通路发生一致性改变,可作为肝癌治疗靶点和预后标志物来源。
研究设计与样本
- 应用系统生物学方法(代谢组学、脂质组学、转录组学)于肝再生、药物及遗传激活的细胞增殖和肝细胞癌模型。
主要发现
- 增殖肝细胞脂质组变化与脂肪生成、脂肪酸去饱和及磷脂酰胆碱生成等代谢通路改变相关。
- 人肝细胞癌中验证了改变的脂质特征,单不饱和磷脂酰胆碱与细胞增殖和肝癌发生标志正相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocytes undergo profound metabolic rewiring when primed to proliferate during compensatory regeneration and in hepatocellular carcinoma (HCC). However, the metabolic control of these processes is not fully understood. In order to capture the metabolic signature of proliferating hepatocytes, we applied state-of-the-art systems biology approaches to models of liver regeneration, pharmacologically and genetically activated cell proliferation, and HCC. APPROACH AND RESULTS: Integrating metabolomics, lipidomics, and transcriptomics, we link changes in the lipidome of proliferating hepatocytes to altered metabolic pathways including lipogenesis, fatty acid desaturation, and generation of phosphatidylcholine (PC). We confirm this altered lipid signature in human HCC and show a positive correlation of monounsaturated PC with hallmarks of cell proliferation and hepatic carcinogenesis. CONCLUSIONS: Overall, we demonstrate that specific lipid metabolic pathways are coherently altered when hepatocytes switch to proliferation. These represent a source of targets for the development of therapeutic strategies and prognostic biomarkers of HCC.
引用
- Hall Z, Chiarugi D, Charidemou E, et al. Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma. Hepatology. 2020. PMID: 32460431. doi:10.1002/hep.31391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。